Close
Almac
Achema middle east

Breaking news:

Proactive Risk Management as a Core Capability in Pharma Development

Risk management in pharma is often treated as a reactive compliance box-ticking exercise. This article argues for reframing risk as a strategic competitive advantage. It…

Popular:

Steps to Compliance: How Best to Prepare for...

Preparing for Russia’s regulation requirements might seem like a...

The Highest Safety for Highly Potent Pharmaceuticals

Biotechnologically manufactured drugs are one of the most important...

Articles

Who are the Top Vendors for Budget-Friendly Laboratory Supplies?

Whether professionals need a high-performance gas chromatography system or...

Future-proof vial filling – How flexibility Along the Line Defines Success

Vial fill-finish operations are changing faster than ever. New...

How Smart Digital Strategies are Leading...

The evolution of pharmaceutical manufacturing is driven largely by...

Rethinking Real-World Data Partnerships: How to...

Noah Nasser, CEO of datma Most pharmaceutical companies have already...

Energy efficiency in pure steam generation:...

Pharmaceutical manufacturers face a twofold challenge. They not only...

Pharmacovigilance Systems Gaining Higher Ground with...

In a world that is marked by fast technological...

Overcoming The Pharmaceutical Supply Chain Disruptions

The pharmaceutical industry is undergoing a profound shift as...

Smart Sensors in Biomanufacturing Transform Fluid...

Smart Sensors & Monitoring in Fluid Systems in Biomanufacturing Precision...

Authors

Interviews

Improving Lab Efficiency Through Equipment Utilization

Q1: How can pharmaceutical laboratories quantify the financial impact...

Trend Forecasting: Insights from Dr. Oliver...

Dr. Oliver Okle is a product and service manager...

Jason Shuris of Indero on the...

Jason Shuris is the Chief Business Officer at Indero,...

Executive Interview Series with datma CEO...

datma is a leading provider of federated Real-World Data...

Ethical AI Investment: The Key to...

In this exclusive interview, World Pharma Today sits down...

White Papers

BioPharma

Press Releases

Syntegon Reports Strong Q3 2025 Growth and Margin Expansion

Syntegon Delivers Strong Growth and Margin Expansion in Q3 2025 with Accelerating Pharma Momentum and Profitability Gains Across All Segments Q3 sales increased by 19% versus prior...

API China – The Pharmaceutical Ingredients Exhibition Concludes

API China, the first and longest-running pharmaceutical ingredients exhibition in China brought in over 30,000 visitors and around 1,200 exhibitors between 12 and 14 November 2025 at...

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country. The investment by Almac...

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical...

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase...

New data from Elsevier finds one in three corporate...

AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D In its latest report, Researcher of the Future,...

KLN Named Exclusive Distributor for Siemens Healthineers Point-of-Care Testing...

KLN Logistics Group Limited announced a strategic partnership between its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), and global medical technology leader Siemens Healthineers AG (Stock Code...

API China Strengthens its Role as Asia’s Pharma Powerhouse

Heads to Chongqing for its 93rd edition API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd edition at the Chongqing International Expo Center from 12–14 November...

swop 2025: Celebrating Ten Years of Industry Growth

Looking Ahead, Seizing New Opportunities — swop 2025 Marks Its 10th Anniversary in Shanghai From November 25–27, 2025, the Shanghai World of Packaging (swop) will return to the...

swop 2025: A Decade of Global Packaging Innovation

A Decade of swop: Enabling Global Packaging Synergy via Integrated Industry Chain in 2025 As globalization advances and China steps up efforts to meet its “dual-carbon” goals (carbon...

Industry Reports

India Outpaces Global Average With 2026 Medical Trend at 11.5 Percent: Aon Reports

Cardiovascular diseases, gastrointestinal conditions and cancer are top medical...

Biopharmaceutical CMO And CRO Market to Reach $60B by 2033

It should be highlighted that during the next ten...

Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation

Eli Lilly, the US pharma giant, has become the...
Achema middle east

Events

29th Edition Strategic Project & Portfolio Management for Pharma

Subscribe

- Gain full access to our premium content

- Never miss a story with active notifications

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Drug Devlopment

Packaging & Labelling

Manufacturing

More News

Largest Vaccine Manufacturing Facility in Egypt Launched

Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the GENNVAX vaccine manufacturing...

Sobi to Get Rights to Pozdeutinurad – Oral URAT1...

For a $950 million upfront, Sobi is all set to get rights to pozdeutinurad - oral URAT1 inhibitor that performed pretty well in the Phase II studies. Sobi...

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with the UK Nuclear Decommissioning Authority (NDA) to utilize reprocessed uranium from nuclear reactors for the production of precision...

US FDA Approves Oral Antibiotic for Treatment of Gonorrhea

On December 12, 2025, the U.S. health regulator went ahead and approved the oral antibiotic by Innoviva for treatment of gonorrhea, which is a common sexually transmitted...

BaseLaunch to Benefit from Biotech Innovation of Takeda

In one of the most prominent developments for the biotech sector, BaseLaunch has officially welcomed Takeda as its new pharmaceutical partner. This collaboration is going to enhance...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost $2.1bn licensing deal with YaoPharma in order to develop as well as commercialize its obesity pill, hence furthering...

Technology Enhancing Early Stage Cancer Detection: High-Performance DNA Probes...

Liquid biopsy has become the quiet revolution of early cancer detection. It helps analyze circulating tumor DNA or tumor cells directly from blood. But behind the buzz...

Technology

Aligning Scientific Innovation with Commercial Reality in Drug...

The "Valley of Death" in pharma is no longer just about scientific failure; it is about commercial irrelevance. This article examines the critical need to…

How Advanced Analytics is Redefining Pharma Project Prioritization

The era of "gut feeling" in pharmaceutical portfolio management is ending. This article explores how advanced analytics, machine learning, and predictive modeling are revolutionizing project…

Rethinking Pipeline Value Beyond Peak Sales Forecasts

The traditional reliance on risk-adjusted Net Present Value (rNPV) and peak sales forecasts is failing to capture the true potential of modern pharmaceutical assets, particularly…

Videos

Loading playlist…
Translate »